Clinical Trial: A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

U.S., Dec. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07309445) titled 'A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States' on Dec. 16.

Brief Summary: The purpose of this study is to assess how well TAR-200 works in real-word by measuring the time taken from the first TAR-200 insertion to worsening of cancer or until the signs and symptoms of cancer occur again (disease-free survival) in participants with non-muscle invasive bladder cancer (NMIBC; an early-stage bladder cancer that is limited to the inner lining of bladder).

Study Start Date: Dec. 18

Study Type: OBSERVATIONAL

Condition: Non-Muscle Invasive Bl...